Markets
Liminatus Pharma, Inc. (LIMN)
LIMNNASDAQ-CMBiotechnology: Biological Products (No Diagnostic Substances)
$2.84
+0.2250 (+8.60%) today
At the close, Nov 10, 4:00 PM ET. After hours $2.77 –
+8.60% 1D
- Market cap
- $3.72m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $2.76 to $2.91
- 52-week range
- $2.40 to $141.50
- Average volume
- 28.2k
- Previous close
- $2.62
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$701.0k | -$884.0k | -$1.10m | -$1.38m |
| Net income | -$1.82m | -$8.17m | -$1.12m | -$1.41m |
News
8 latest- Liminatus Pharma Regains Nasdaq Compliance Following 1-For-50 Reverse Split RTTNews · Sep 30, 2026
- Liminatus Pharma Announces 1-for-50 Reverse Stock Split; Stock Down RTTNews · Aug 19, 2026
- Liminatus Pharma Transfers To Nasdaq Capital Market; Shares Surge In Pre-Market RTTNews · Aug 13, 2026
- Liminatus Pharma Amends Merger Agreement With InnocsAI To Expand Oncology Pipeline RTTNews · Jul 1, 2026
- Liminatus Pharma Enters Into $1.9 Mln Warrant Exercise Transaction RTTNews · Jun 4, 2026
- Liminatus Pharma Prices $4 Mln Offering Of Shares And Warrants; Stock Down RTTNews · Feb 17, 2026
- Pre-Market Most Active for Aug 22, 2025 : LIMN, LCID, INTC, SQQQ, TSLL, OPENNASDAQ.com · Aug 22, 2025
- Pre-Market Most Active for Jul 24, 2025 : TSLL, OPEN, LIMN, AAL, TSLA, TSLQ, NIO, CIO, PCG, CMG, AEO, DOWNASDAQ.com · Jul 24, 2025
The company
Liminatus Pharma, Inc. (Nasdaq: LIMN) is a biotechnology company developing innovative immuno-oncology and cell therapy candidates. The Company's portfolio includes IBA101, a next-generation anti-CD47 monoclonal antibody, as well as oncology-focused cellular therapy programs including IBC101, a CD19xCD22 bivalent CAR-T candidate for B-cell malignancies. Liminatus is focused on advancing differentiated therapeutic approaches designed to address unmet needs in cancer treatment.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- liminatuspharma.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.